Breast lumps
You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.
|
WikiDoc Resources for Breast lumps | |
|
Articles | |
|---|---|
|
Most recent articles on Breast lumps Most cited articles on Breast lumps | |
|
Media | |
|
Powerpoint slides on Breast lumps | |
|
Evidence Based Medicine | |
|
Clinical Trials | |
|
Ongoing Trials on Breast lumps at Clinical Trials.gov Clinical Trials on Breast lumps at Google
| |
|
Guidelines / Policies / Govt | |
|
US National Guidelines Clearinghouse on Breast lumps
| |
|
Books | |
|
News | |
|
Commentary | |
|
Definitions | |
|
Patient Resources / Community | |
|
Patient resources on Breast lumps Discussion groups on Breast lumps Patient Handouts on Breast lumps Directions to Hospitals Treating Breast lumps Risk calculators and risk factors for Breast lumps
| |
|
Healthcare Provider Resources | |
|
Causes & Risk Factors for Breast lumps | |
|
Continuing Medical Education (CME) | |
|
International | |
|
| |
|
Businness | |
|
Experimental / Informatics | |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Phone:617-525-6884
Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Epidemiology and Demographics
- 40% of breast complaints leading to an office visit
- 6% of all women ages 40-69 seek advice about breast lumps
- Cysts and fibroadenomas = most common underlying conditions
- 75-80% of breast biposies in the US are for benign lesions
- Breast cancer detected in
- 4% of women with breast complaints
- 8% of women with abnormal screening mammograms
- 2% of women with abnormal findings on screening clinical breast exam
Breast Cancer Risk Factors
Breast Cancer Risk Factors
| Age (> 70 vs. < 35) | RR 17.0 |
| Positive Family History | RR 2.6 |
| Early Menarche (< 12 years old) | RR 1.5 |
| Late Menopause (> 55 years old) | RR 2.0 |
| HRT Use (current) | RR 1.2-1.4 |
| OCP Use (ever) | RR 1.07-1.2 |
| Postmenopausal Body Mass Index (> 30.7) | RR 1.6 |
Pathophysiology & Etiology
- Cysts
- Common in premenopausal women > 40 years old
- Less frequent in younger women (10% of breast masses in women < 40 years old)
- Uncommon in postmenopausal women not on hormone replacement therapy (HRT)
- Often fluctuate with menstrual cycle
- Especially common during periods of hormonal irregularity
- Fibroadenomas
- Prominent Fibrocystic Change (without a dominant mass)
- Fat Necrosis
- Malignancy
Diagnosis
- Triple Diagnosis
- Use of physical examination, mammogram and fine needle aspiration biopsy (FNAB) for diagnosis of palpable lumps
- If all 3 are benign: < 1% incidence of breast cancer
- Follow patient with complete breast exam (CBE) every 3-6 months x 1 year to ensure stability
- If all 3 are positive: 99.4% incidence breast cancer
- If any 1 is positive: excisional biopsy recommended
- If all 3 are benign: < 1% incidence of breast cancer
- Use of physical examination, mammogram and fine needle aspiration biopsy (FNAB) for diagnosis of palpable lumps
Differential Diagnosis of a Breast Lump
- Breast Abscess
- Breast Cancer
- Carcinoma
- Cyst
- Cystic mastitis
- Cystosarcoma Phylloides
- Fat necrosis
- Fibroadenoma
- Fibrocystic changes
- Galactocele
- Gynecomastia
- Hematoma
- Intraductal papilloma
- Lipoma
- Lymphoma
- Mammary adenosis
- Mammary duct ectasia
- Phylloides tumor
- Prolactinoma
- Sebaceous cyst
- Trauma
- Tuberculosis abscess
History and Symptoms
- Characteristics of lump:
- Location and duration of its presence, changes in size
- Associated nipple discharge
- Changes with menstrual cycle
- Cysts tend to be more prominent
- Premenstrually and may regress during follicular phase
- Tenderness
- Rapidly developing cysts may be tender
- Prior history of breast cancer or breast biopsy (atypical hyperplasia on prior biopsy most worrisome)
Physical Examination
- Suspicious findings
- Single lesion
- Hard
- Immobile
- Irregular borders
- Size > 2 cm
- Exam not reliable for distinguishing benign vs. malignant (PPV 73%, NPV 87% at referral center)
- Cancers may be tender on exam (~ 15% of cases)
- Exam should include evaluation for supraclavicular and axillary LAN
Echocardiography or Ultrasound
- Ultrasonography:
- In women < 35
- May be helpful in conjunction with mammogram for women 35 and over
- Also for evaluation of nonpalpable mass detected on screening mammogram
- Simple cyst on ultrasound has extremely low risk cancer
Other Imaging Findings
Mammography
- Any woman age 35 or over with a breast mass
- Suspicious findings
- Increased density
- Irregular margins
- Spiculation
- Clustered
- Microcalcifications
- Can miss 10-20% of clinically palpable breast cancers
- Not cost-effective or clinically helpful in patients < 35 unless high suspicion cancer
Other Diagnostic Studies
Fine Needle Aspiration/Biopsy
- Fine Needle Aspiration
- Office procedure for evaluation of palpable cyst (22-24 gauge needle)
- Bloody fluid
- Send for cytology and refer for surgical biopsy
- Non-bloody fluid
- Cytology extremely low yield (do not send)
- If mass disappears, reexamine pt in 4-6 weeks
- If no recurrence, resume routine follow-up
- If recurrence, can repeat aspiration
- Consider biopsy if further recurrence
- Non-bloody fluid but residual mass after aspiration: surgical biopsy
- Solid mass (no fluid)
- Surgical biopsy or fine needle aspiration biopsy
- Fine Needle Aspiration Biopsy (FNAB)
- Aspiration of cells from a solid mass
- 21 gauge needle, operator-dependent
- Wide variation in sens (65-98%), spec (34-100%)
- Core Needle Biopsy
- 14-18 gauge needle allows for better histologic sample
- Used mostly for evaluation of non-palpable masses (mammogram or ultrasound guidance)
- Compares favorably with surgical biopsy at lower cost
- Excisional Biopsy
- Recommended if solid mass suspicious for cancer by exam or mammo
- Also recommended for palpable mass not seen on mammogram or for abnormal biopsy
Treatment
Recommendations
- Women < age 35
- If no distinct lump found or primary care physician (PCP) unsure: refer to breast specialist for 2nd opinion
- If non-suspicious lump on exam
- Reassess 3-10 days after onset of next menses
- If lump regresses, no further evaluation needed
- If lump remains palpable and feels cystic
- Fine needle aspiration (FNA)
- Management of bloody vs. non-bloody fluid as above
- If lump does not feel cystic
- Ultrasound
- If solid mass: FNAB, core biopsy or excisional biopsy
- If cyst, FNA as above
- If non-suspicious solid mass < 1 cm: likely fibroadenoma
- Can follow by physical examination every 3-6 months
- Mammography generally not helpful in this age group
- Women age 35 and over
- Mammography and ultrasonography (note: mammography has 10-20% false-negative rate)
- Cystic mass
- FNA with mgmt of bloody vs. non-bloody fluid as above
- Solid mass
- Core biopsy, FNAB or excisional biopsy if no suspicious features
- Excisional biopsy recommended if mass is suspicious by exam or mammogram
- No specific findings on mammogram and ultrasound: refer to surgeon for likely excision
Acknowledgements
The content on this page was first contributed by: Rebecca Cunningham, M.D.
List of contributors:
Suggested Reading and Key General References
Suggested Links and Web Resources
For Patients
Acknowledgement and Attribution Regarding Sources of Content
Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .

